All Type of News
Wanting to get its patent back, Alcon has finally been defeated against the Korea Intellectual Property Office
Alcon, which has been arguing to get its patent back, has finally ended up gulping up its tears.
According to the industry concerned, the Supreme Court has recently decided the defeat of the plaintiff in the case rel...
Green Cross build a domestic bio factory in Northern America for the first time as a Korean pharmaceutical companyGreen Cross announced on the 2nd that it held the groundbreaking ceremony for the new factory of its domestic branch, Green Cross Biotherapeutics (hereinafter referring to GCBT)...
|
Kwang Dong Pharmaceutical signed the exclusive sales and distribution contract of the GSK’s 8 vaccine productsKwang Dong Pharmaceutical has signed a contract to sell and distribute vaccines with GlaxoSmithKline (GSK) Korea.
The company announced through the ‘Future Business Management ...
|
The relieved Korean Medical Association and the up and down Korean Hospital Association at the 2016 cost negotiation
Like the last year, clinics and pharmacies have played decent games in the cost negotiation of the year.
Hospitals, seeming have advantages in the negotiation due to variations of the collateral condition such as sub...
Lilly Korea has started to exclusively sell ‘Cialis’ since the last monthIt is observed that Lilly Korea has exclusively sold the impotency drug, Cialis, which expecting entry of its generics by its expiration on the coming September, since the last ...
|
Would the once-a-week injector ‘Trulicity’ alter the once-a-day pattern?
While GLP-1 analogues have attracted interests of the industry due to obesity control as well as the hypoglycemic function, the injection-type GLP-1 analogue ‘Trulicity (generic name: dulaglutide),’ which can be injec...
Over 30% of the total sales of domestic pharmaceutical companies are products of multinational pharmaceutical companies
It is observed that the sales proportion of other companies’ products against the total sales of domestic pharmaceutical companies has exceeded 30%.
That is, as domestic pharmaceutical companies suffered from sales d...
Domestic pharmaceutical companies win on the formulation patent trial over Cialis
In regards to ‘Cialis,’ the impotency treatment which will be expired in its substance patent on the coming September, the first trial decision has been made against patent challenges of domestic pharmaceutical compan...
What is the reason why Daewoong Pharmaceutical was interested in Hanall Biopharma, followed by Yuhan Corporation?Followed by Yuhan Corporation which purchased 8.95% of the Hanall Biopharma’s total shares three years ago, Daewoong Pharmaceutical attracted interests of the industry as buying...
|
How far pharmaceutical stocks will go?
On the 1st, according to the Daily Pharm’s aggregation and analysis result of the last May’s total market capitalization of 34 KOSPI pharmaceutical companies, they increased 18.6% up over the one in 2014, surpassing t...
